Alkermes (ALKS) Assets Average (2011 - 2026)
Alkermes (ALKS) reported Assets Average of $3.4 billion for Q1 2026, up 63.02% year-over-year from $2.1 billion in Q1 2025, and up 40.04% quarter-over-quarter from $2.4 billion in Q4 2025.
Alkermes (ALKS) Assets Average (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Assets Average data on file, last reported at $3.4 billion in Q1 2026.
- Assets Average for Q1 2026 came in at $3.4 billion, up 63.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 billion (up 63.02% YoY), and the FY2025 annual result was $2.3 billion, up 8.37% from the prior year.
- Assets Average climbed to $3.4 billion in Q1 2026 per ALKS's latest filing, from $2.4 billion in the prior quarter.
- Over five years, Assets Average peaked at $3.4 billion in Q1 2026 and troughed at $1.9 billion in Q1 2023.
- A 5-year average of $2.2 billion and a median of $2.1 billion in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average slipped 4.63% in 2024, then surged 63.02% in 2026.
- A 5-year view of Assets Average shows it stood at $2.0 billion in 2022, then advanced by 13.05% to $2.2 billion in 2023, then fell by 4.63% to $2.1 billion in 2024, then rose by 14.38% to $2.4 billion in 2025, then jumped by 40.04% to $3.4 billion in 2026.
- Business Quant data shows ALKS's Assets Average at $3.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 364.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.37 Bn |
| Dec 31, 2025 | 2.41 Bn |
| Sep 30, 2025 | 2.29 Bn |
| Jun 30, 2025 | 2.17 Bn |
| Mar 31, 2025 | 2.07 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 2.17 Bn |
| Mar 31, 2024 | 2.13 Bn |
| Dec 31, 2023 | 2.21 Bn |
| Sep 30, 2023 | 2.23 Bn |
| Jun 30, 2023 | 2.05 Bn |
| Mar 31, 2023 | 1.94 Bn |
| Dec 31, 2022 | 1.95 Bn |
| Sep 30, 2022 | 1.95 Bn |
| Jun 30, 2022 | 1.97 Bn |
| Mar 31, 2022 | 2.00 Bn |
| Dec 31, 2021 | 2.01 Bn |
| Sep 30, 2021 | 1.97 Bn |
| Jun 30, 2021 | 1.91 Bn |